Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
ANIPthis companyANI Pharmaceuticals, Inc.	$68.32	22.55×	2.93×	1.79×	7.83×	1187.9%	51.0%	9.2%	8.9%	14.5%	5.6%	9.5%	0.6×	0.19×	4.05×	2.71×	0.1%	7	2.58	3	B
AMPHAmphastar Pharmaceuticals, Inc.	$28.90	12.75×	1.59×	1.74×	8.18×	241.3%	49.5%	19.5%	13.6%	12.4%	7.5%	9.7%	0.83×	2.29×	5.51×	4.02×	0.0%	6	2.19	4	A-
AMRXAmneal Pharmaceuticals, Inc.	$20.94	54.78×	-55.77×	1.31×	10.56×	-33.0%	37.6%	14.0%	2.4%	-101.8%	13.8%	6.8%	-38.65×	4.02×	1.75×	2.17×	0.0%	7	2.58	3	B
COLLCollegium Pharmaceutical, Inc.	$24.69	23.38×	4.87×	1.88×	5.38×	2688.6%	59.3%	24.0%	8.1%	20.8%	10.2%	22.3%	3.12×	1.72×	2.27×	1.57×	0.0%	5	0.95	3	B-
EOLSEvolus, Inc.	$6.75	-8.31×	-18.55×	1.44×	-23.52×	27.2%	64.9%	-12.7%	-17.4%	223.5%	-24.6%	-11.8%	-6.71×	-4.49×	-1.91×	1.9×	0.0%	3	-1.44	2	C
HROWHarrow Health, Inc.	$26.41	-350×	34.35×	6.61×	47×	-1507.5%	75.1%	14.2%	-1.9%	-9.8%	12.7%	2.4%	4.8×	4.25×	1.6×	2.2×	0.0%	4	1.85	1	C-
Peer median	—	12.75×	1.59×	1.74×	8.18×	27.2%	59.3%	14.2%	2.4%	12.4%	10.2%	6.8%	0.83×	2.29×	1.75×	2.17×	0.0%	5	1.85	3	—